Download PDF
Thromb Haemost 2004; 91(01): 1-3
DOI: 10.1055/s-0037-1614255
Editorial Focus
Schattauer GmbH

The physiologic basis of assembly and activation of the plasma kallikrein/kinin system

Alvin H. Schmaier
1   Department of Internal Medicine, Division of Hematology and Oncology and the Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA
› Author Affiliations
Further Information

Publication History

Received 28 October 2003

Accepted 30 October 2003

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Shariat-Madar Z, Schmaier AH. Kininogencytokeratin 1 interactions in endothelial cell biology. Trends Cardiovasc Med 1999; 09: 238-44.
    CrossrefPubMedGoogle Scholar
  • 2 Hasan AAK, Warnock M, Nieman M. et al. The mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin. Amer J. Physiol Heart Circ Physiol 2003; 285: H183-93.
    PubMedGoogle Scholar
  • 3 Chavakis T, Boeckel N, Santoso S. et al. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high moledular weight kininogen. J Biol Chem 2002; 277: 23157-64.
    CrossrefPubMedGoogle Scholar
  • 4 Chavakis T, Pixley RA, Isordia-Salas I. et al. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function. J Biol Chem 2002; 277: 32677-82.
    CrossrefPubMedGoogle Scholar
  • 5 Chavakis T, Kanse SM, Pixley RA. et al. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J 2001; 15: 2365-76.
    CrossrefPubMedGoogle Scholar
  • 6 Herwald H, Dedio J, Kellner R. et al. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. J Biol Chem 1996; 271: 13040-47.
    CrossrefPubMedGoogle Scholar
  • 7 Joseph K, Ghebrehiwet B, Peerschke EIB. et al. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular “heads” of C1q (gC1qR). Proc Natl Acad Sci USA 1996; 93: 8552-7.
    CrossrefPubMedGoogle Scholar
  • 8 Colman RW, Pixley RA, Najamunnisa S. et al. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest 1997; 100: 1481-7.
    CrossrefPubMedGoogle Scholar
  • 9 Hasan AAK, Zisman T, Schmaier AH. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci USA 1998; 95: 3615-20.
    CrossrefPubMedGoogle Scholar
  • 10 Zhang JC, Donate F, Qi X. et al. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin. Proc Natl Acad Sci USA 2002; 99: 12224-9.
    CrossrefPubMedGoogle Scholar
  • 11 Mahdi F, Shariat-Madar Z, Todd III RF. et al. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 2001; 97: 2342-50.
    CrossrefPubMedGoogle Scholar
  • 12 Mahdi F, Shariat-Madar Z, Schmaier AH. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells. J Biol Chem 2003; 278: 43983-90.
    CrossrefPubMedGoogle Scholar
  • 13 Baird TR, Walsh PN. Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation. J BiolChem 2002; 32: 28498-503.
    PubMedGoogle Scholar
  • 14 Schleef RR, Podor TJ, Dunne E. et al. The majority of type 1 plasminogen activator inhibitor associate with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol 1990; 110: 155-63.
    CrossrefPubMedGoogle Scholar
  • 15 Motta G, Shariat-Madar Z, Mahdi F. et al. Assembly and activation of high molecular weight kininogen and prekallikrein on cell matrix. Thromb Haemost 2001; 86: 840-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Joseph K, Tholanikunnel BG, Ghebrehiwet B. et al. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost 2004; 91: 61-70.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Mahdi F, Shariat-Madar Z, Figueroa C. et al. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial membranes. Blood 2002; 99: 3585-96.
    CrossrefPubMedGoogle Scholar
  • 18 Shariat-Madar Z, Mahdi F, Schmaier AH. Factor XI assembly and activation on human umbilical vein endothelial cells in culture. Thromb Haemost 2001; 85: 544-51.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Shariat-Madar Z, Schmaier AH. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation. Int Immunopharmacol 2002; 02: 1841-9.
    CrossrefPubMedGoogle Scholar
  • 20 Motta G, Rojkjaer R, Hasan AAK. et al. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood 1998; 91: 516-28.
    PubMedGoogle Scholar
  • 21 Rojkjaer R, Hasan AAK, Motta G. et al. Factor XII does not initiate prekallikrein activation on endothelial cells. Thromb Haemost 1998; 80: 74-81.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Shariat-Madar Z, Mahdi F, Schmaier AH. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 2002; 277: 17969-69.
    PubMedGoogle Scholar
  • 23 Moreira CR, Schmaier AH, Mahdi F. et al. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS-Lett 2002; 523: 167-70.
    CrossrefPubMedGoogle Scholar
  • 24 Joseph K, Tholianikunnel BG, Kaplan AP. Heat shock protein 90 catalyzes activation of prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci USA 2002; 99: 896-900.
    CrossrefPubMedGoogle Scholar